Literature DB >> 12176113

Activation of RNA-dependent protein kinase and nuclear factor-kB by regulatory RNA from lipopolysaccharide-stimulated macrophages: implications for cytokine production.

Fernando L De Lucca1, Sergio V Serrano, Liliana R Souza, Maria Angelica E Watanabe.   

Abstract

Our previous results showed that L-RNA, extracted from lipopolysaccharide-stimulated macrophages, induces interleukin-1, interleukin-8 and tumor necrosis factor-alpha (TNF-alpha) in resident macrophages. It was demonstrated the promoter of these cytokine genes contain nuclear factor-kB (NF-kappa B) binding sites. We hypothesized that this effect of L-RNA is mediated by RNA-dependent protein kinase (PKR) through NF-kappa B activation. We found that L-RNA activates PKR and induces NF-kappa B activation through degradation of its inhibitor I-kappa B alpha. These data support the idea that L-RNA acts as a regulatory RNA. A model for the mechanism of action of L-RNA is proposed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12176113     DOI: 10.1016/s0014-2999(02)02072-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Regulatory RNA induces the production of IFN-gamma, but not IL-4 in human lymphocytes: role of RNA-dependent protein kinase (PKR) and NF-kappaB.

Authors:  Fernando L De Lucca; Valeria S F Sales; Liliana R Souza; Joana M Murad; Maria Angelica E Watanabe
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

2.  Neuroprotective Effects of Ginsenoside-Rg1 Against Depression-Like Behaviors via Suppressing Glial Activation, Synaptic Deficits, and Neuronal Apoptosis in Rats.

Authors:  Cuiqin Fan; Qiqi Song; Peng Wang; Ye Li; Mu Yang; Shu Yan Yu
Journal:  Front Immunol       Date:  2018-12-07       Impact factor: 7.561

3.  Nuclear PKR in retinal neurons in the early stage of diabetic retinopathy in streptozotocin‑induced diabetic rats.

Authors:  Viviane Aline Oliveira Silva; Nayara Delgado André; Thaís Amaral E Sousa; Vâni Maria Alves; Isis Do Carmo Kettelhut; Fernando Luiz De Lucca
Journal:  Mol Med Rep       Date:  2021-06-29       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.